Charisma Medical and Research Center — Miami Lakes, Florida

Charisma Medical and Research Center is a clinical research site located in Miami Lakes, Florida, United States 33014.

Crixeo Clinical Trials Trust Score: 18/100 (FAILING). This profile has not yet been claimed by the site owner.

Charisma Medical and Research Center has participated in 9 clinical trials with 5 currently active.

Therapeutic areas: Clostridioides Difficile Associated Disease, Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus.

Sponsors: Pfizer, Biogen, Nova Biomedical.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Miami Lakes

Browse all research sites in Florida · View every site in Miami Lakes

Sponsor Feasibility Report

Trust Score: 18/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Charisma Medical and Research Center?

Charisma Medical and Research Center has a Crixeo Trust Score of 18/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Charisma Medical and Research Center conducted?

Charisma Medical and Research Center has 9 clinical trials on record, with 5 currently active. Their work covers Clostridioides Difficile Associated Disease, Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus.

Is Charisma Medical and Research Center accredited by Crixeo Clinical Trials?

Charisma Medical and Research Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Charisma Medical and Research Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.